Balanced Pharma Inc
CIK 1838860 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Balanced Pharma Inc.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 23, 2025 | D/A | 0001838860-25-000007 |
| Jan 15, 2025 | D | 0001838860-25-000001 |
| Dec 12, 2024 | D | 0001838860-24-000002 |
| Dec 12, 2024 | D | 0001838860-24-000003 |
| Sep 6, 2023 | 1-Z | 0001104659-23-098411 |
| May 1, 2023 | 1-K | 0001104659-23-053330 |
| Mar 30, 2023 | 253G2 | 0001104659-23-039255 |
| Sep 16, 2022 | 1-SA | 0001104659-22-100549 |
| Aug 18, 2022 | 253G2 | 0001104659-22-092461 |
| Jul 20, 2022 | 253G2 | 0001104659-22-080938 |
| Jul 19, 2022 | 1-U | 0001104659-22-080823 |
| Apr 11, 2022 | 253G2 | 0001104659-22-044420 |
| Apr 8, 2022 | QUALIF | 9999999994-22-000144 |
| Mar 21, 2022 | 1-A | 0001104659-22-035773 |
| Feb 18, 2022 | D/A | 0001838860-22-000001 |
| Jan 7, 2021 | D | 0001838860-21-000001 |